Prostate-specific Membrane Antigen: Alpha-labeled Radiopharmaceuticals

被引:1
|
作者
Ndlovu, Honest [1 ,2 ,3 ]
Mokoala, Kgomotso M. G. [1 ,2 ,3 ]
Lawal, Ismaheel [2 ,3 ,4 ]
Emmett, Louise [5 ]
Sathekge, Mike M. [1 ,2 ,3 ]
机构
[1] Steve Biko Acad Hosp, Nucl Med Res Infrastruct NuMeRI, Pretoria, South Africa
[2] Univ Pretoria, Dept Nucl Med, Private Bag X169, ZA-0001 Pretoria, South Africa
[3] Steve Biko Acad Hosp, Private Bag X169, ZA-0001 Pretoria, South Africa
[4] Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA USA
[5] St Vincents Hosp Sydney, Theranost & Nucl Med, Sydney, Australia
关键词
Targeted alpha therapy; Prostate cancer; PSMA; Ac-225]Ac-PSMA-617; Clinical practice; TARGETED TH-227 CONJUGATE; QUALITY-OF-LIFE; RADIOLIGAND THERAPY; RADIONUCLIDE THERAPY; LU-177-PSMA THERAPY; DOSIMETRY ESTIMATE; CANCER; PSMA; EXPRESSION; EFFICACY;
D O I
10.1016/j.cpet.2024.03.003
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
[No abstract available]
引用
收藏
页码:371 / 388
页数:18
相关论文
共 50 条
  • [1] Current Status of Prostate-specific Membrane Antigen-targeted Alpha Radioligand Therapy in Prostate Cancer
    Yamamichi, Gaku
    Kato, Taigo
    Watabe, Tadashi
    Hatano, Koji
    Uemura, Motohide
    Nonomura, Norio
    ANTICANCER RESEARCH, 2024, 44 (03) : 879 - 888
  • [2] Prostate specific membrane antigen binding radiopharmaceuticals: Current data and new concepts
    Sartor, Oliver
    Baghian, Ali
    FRONTIERS IN MEDICINE, 2022, 9
  • [3] Recent Advances in Prostate-Specific Membrane Antigen-Based Radiopharmaceuticals
    Diao, Wei
    Cai, Huawei
    Chen, Lihong
    Jin, Xi
    Liao, Xinyang
    Jia, Zhiyun
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (01) : 33 - 56
  • [4] Prostate-Specific Membrane Antigen-Negative MetastasesA Potential Pitfall in Prostate-Specific Membrane Antigen PET
    Noto, Benjamin
    Springe, Katharina Auf Der
    Huss, Sebastian
    Allkemper, Thomas
    Stegger, Lars
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (06) : E186 - E188
  • [5] Recent developments of prostate-specific membrane antigen (PSMA)-specific radiopharmaceuticals for precise imaging and therapy of prostate cancer: an overview
    Okarvi, Subhani M.
    CLINICAL AND TRANSLATIONAL IMAGING, 2019, 7 (03) : 189 - 208
  • [6] Prostate-specific Membrane Antigen Diagnostics
    Alberts, Ian L.
    Seifert, Robert
    Werner, Rudolf A.
    Rowe, Steven P.
    Afshar-Oromieh, Ali
    PET CLINICS, 2024, 19 (03) : 351 - 362
  • [7] Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer
    Paschalis, Alec
    Sheehan, Beshara
    Riisnaes, Ruth
    Rodrigues, Daniel Nava
    Gurel, Bora
    Bertan, Claudia
    Ferreira, Ana
    Lambros, Maryou B. K.
    Seed, George
    Yuan, Wei
    Dolling, David
    Welti, Jon C.
    Neeb, Antje
    Sumanasuriya, Semini
    Rescigno, Pasquale
    Bianchini, Diletta
    Tunariu, Nina
    Carreira, Suzanne
    Sharp, Adam
    Oyen, Wim
    de Bono, Johann S.
    EUROPEAN UROLOGY, 2019, 76 (04) : 469 - 478
  • [8] Advances in prostate-specific membrane antigen PET of prostate cancer
    Bouchelouche, Kirsten
    Choyke, Peter L.
    CURRENT OPINION IN ONCOLOGY, 2018, 30 (03) : 189 - 196
  • [9] Prostate-Specific Membrane Antigen-Targeted Theranostics: Past, Present, and Future Approaches
    Hawkey, Nathan M.
    Sartor, Alton O.
    Morris, Michael J.
    Armstrong, Andrew J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (04) : 227 - 238
  • [10] Prostate-specific membrane antigen-based imaging
    Osborne, Joseph R.
    Akhtar, Naveed H.
    Vallabhajosula, Shankar
    Anand, Alok
    Deh, Kofi
    Tagawa, Scott T.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (02) : 144 - 154